Literature DB >> 65023

HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML).

E Goulmy, A Termijtelen, B A Bradley, J J van Rood.   

Abstract

The aim of our study was to define target determinants other than those coded for by the classical HLA-A, -B, -C or -D loci which were responsible for killing in CML. In one of the families studied, strong evidence was found for the existence of a determinant coded for within the HLA region. CML was restricted to targets carrying the classical HLA-Bw35 and Cw4 determinants but the targets were neither HLA-Bw35 nor Cw4 themselves. We therefore concluded that this new HLA determinant was either the product of a new locus closely associated with HLA-B or that it was a product of the classical HLA-B locus which has not been recognized by serology.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 65023     DOI: 10.1111/j.1399-0039.1976.tb00583.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  13 in total

1.  Interaction between des-Tyr1-gamma-endorphin and HLA class I molecules: serological detection of an HLA-A2 subtype.

Authors:  F H Claas; J J van der Poel; R Castelli-Visser; J Pool; R B Chen; K Y Xu; J J van Rood
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Differential behavior of cytotoxic effector cells against HLA antigens in strong genetic linkage disequilibrium.

Authors:  S J Kim; F T Christiansen; D M Silver; B Dupont
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

3.  Analysis of the functional epitopes on different HLA-A2 molecules.

Authors:  E Goulmy; J van der Poel; M Giphart; J J van Rood
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

4.  The monoclonal antibody CR11-351 discriminates HLA-A2 variants identified by T cells.

Authors:  C Russo; A K Ng; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

5.  Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. II. Definition of three HLA-A2 subtypes by CTLs.

Authors:  J J van der Poel; J Pool; E Goulmy; J J van Rood
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Differential recognition of the serologically defined HLA-A2 antigen by allogeneic cytotoxic T cells. I. Population studies.

Authors:  S Horai; J J van der Poel; E Goulmy
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Primed lymphocyte testing specificity of alloreactive lymphocyte clones for HLA-B locus determinants.

Authors:  A Zeevi; C Scheffel; K Annen; R J Duquesnoy
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

8.  Specific active immunotherapy for melanoma.

Authors:  H F Seigler; E Cox; F Mutzner; L Shepherd; E Nicholson; W W Shingleton
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

9.  MHC-linked class III genes. Analysis of C4 gene frequencies, complotypes and associations with distinct HLA haplotypes in German Caucasians.

Authors:  D J Schendel; G J O'Neill; R Wank
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  In vitro-isolated human cytotoxic T-lymphocyte clones detect variations in serologically defined HLA antigens.

Authors:  H Spits; M Breuning; P Ivanyi; C Russo; J E de Vries
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.